Analytical Data
-
Gene name
FAM62B
- Application
-
Alternative Names
ESYT2; FAM62B; KIAA1228Extended synaptotagmin-2; E-Syt2; Chr2Syt
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A0FGR8
-
Expression Region
1-358aa
-
AA Sequence
MSVGHKAQESKIRYKTNEPVWEENFTFFIHNPKRQDLEVEVRDEQHQCSLGNLKVPLSQLLTSEDMTVSQRFQLSNSGPNSTIKMKIALRVLHLEKRERPPDHQHSAQVKRPSVSKEGRKTSIKSHMSGSPGPGGSNTAPSTPVIGGSDKPGMEEKAQPPEAGPQGLHDLGRSSSSLLASPGHISVKEPTPSIASDISLPIATQELRQRLRQLENGTTLGQSPLGQIQLTIRHSSQRNKLIVVVHACRNLIAFSEDGSDPYVRMYLLPDKRRSGRRKTHVSKKTLNPVFDQSFDFSVSLPEVQRRTLDVAVKNSGGFLSKDKGLLGKVLVALASEELAKGWTQWYDLTEDGTRPQAMT
-
Molecular Weight
65.12 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM62B, a member of the family of protein-coding genes, has garnered attention in recent years due to its potential roles in cellular processes and various diseases. Initially identified through genomic studies, FAM62B is thought to be involved in cell proliferation, differentiation, and apoptosis, making it a gene of interest in cancer research. Abnormal expression of FAM62B has been linked to several malignancies, suggesting that it could serve as a biomarker for tumor progression or a potential therapeutic target. Recent studies have focused on understanding the functional mechanisms of FAM62B, particularly its interactions with other cellular proteins and its impact on signaling pathways associated with cancer. Additionally, the characterization of recombinant FAM62B protein has provided insights into its structure and biological function. This research enhances our understanding of its role in cellular homeostasis and disease pathology. As the scientific community continues to explore the implications of FAM62B, there is a growing interest in developing recombinant forms of this protein for further study, which could help elucidate its function and therapeutic potential. Overall, the investigation of FAM62B represents a promising area in molecular biology and cancer research, with the aim of translating findings into clinical applications for improved diagnosis and treatment strategies.
